Triple
T23417460
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Bristol Myers Squibb |
E560549
|
entity |
| Predicate | product |
P490
|
FINISHED |
| Object | Breyanzi |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Breyanzi | Statement: [Bristol Myers Squibb, product, Breyanzi]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Breyanzi Context triple: [Bristol Myers Squibb, product, Breyanzi]
-
A.
Beutler
Beutler is a surname most notably associated with Bruce A. Beutler, an American immunologist and Nobel Prize laureate recognized for his work on innate immunity.
-
B.
Trikafta
Trikafta is a breakthrough combination therapy for cystic fibrosis that targets the underlying genetic defect to improve lung function and reduce symptoms in eligible patients.
-
C.
Ultomiris
Ultomiris is a long-acting monoclonal antibody therapy used to treat rare complement-mediated blood disorders such as paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
-
D.
Onpattro
Onpattro is an RNA interference (RNAi) therapeutic used to treat polyneuropathy in adults with hereditary transthyretin-mediated (hATTR) amyloidosis.
-
E.
Bantigen
Bantigen is a small locality within the municipality of Bolligen in the canton of Bern, Switzerland.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Breyanzi Target entity description: Breyanzi is a CD19-directed CAR T-cell therapy used to treat certain types of relapsed or refractory large B-cell lymphoma.
-
A.
Beutler
Beutler is a surname most notably associated with Bruce A. Beutler, an American immunologist and Nobel Prize laureate recognized for his work on innate immunity.
-
B.
Trikafta
Trikafta is a breakthrough combination therapy for cystic fibrosis that targets the underlying genetic defect to improve lung function and reduce symptoms in eligible patients.
-
C.
Ultomiris
Ultomiris is a long-acting monoclonal antibody therapy used to treat rare complement-mediated blood disorders such as paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
-
D.
Onpattro
Onpattro is an RNA interference (RNAi) therapeutic used to treat polyneuropathy in adults with hereditary transthyretin-mediated (hATTR) amyloidosis.
-
E.
Bantigen
Bantigen is a small locality within the municipality of Bolligen in the canton of Bern, Switzerland.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454cb1108190ab21ada5411a7146 |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1a516d158819081e9710b4e372a21 |
completed | April 29, 2026, 6:28 a.m. |
Created at: April 17, 2026, 5:39 p.m.